Skip to Content

Join the 'Lipodystrophy' group to help and get support from people like you.

Lipodystrophy News

Myalept Approved for Rare Fat Tissue Disorder

Posted 25 Feb 2014 by Drugs.com

TUESDAY, Feb. 25, 2014 – Myalept (metreleptin for injection) has been approved by the U.S. Food and Drug Administration to treat complications of leptin deficiency for people with the congenital or acquired generalized forms of lipodystrophy. The disorder is associated with a lack of fat tissue. Leptin, produced by fat tissue, is a hormone that helps regulate food intake and other hormones such ...

FDA Approves Myalept to Treat Generalized Lipodystrophy

Posted 25 Feb 2014 by Drugs.com

February 25, 2014 – On Feb. 24, 2014, the U.S. Food and Drug Administration approved Myalept (metreleptin for injection) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired generalized lipodystrophy. Generalized lipodystrophy is a condition associated with a lack of fat tissue. Patients with congenital ...

Ask a Question

Further Information

Related Drug Support Groups

Egrifta, tesamorelin, metreleptin, Myalept